Literature DB >> 26384822

Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome.

Guillermo Delgado-García1, Carlos Cámara-Lemarroy2, Adrián Infante-Valenzuela2, Perla Colunga-Pedraza3, Gabriela Alarcón-Galván4, Arian Armenta-González5, Héctor Jorge Villarreal-Velázquez2.   

Abstract

Lupus podocytopathy (LP) is an uncommon proteinuric disorder in the spectrum of lupus nephropathy. Its histological features are similar to those described in minimal change disease (MCD) with or without mesangial immune deposits. Although infrequent, a close relationship between systemic lupus erythematosus (SLE) and thrombotic thrombocytopenic purpura (TTP) is well accepted. Proteinuria in the setting of SLE has previously been associated with the development of TTP-like syndrome. As far as we know, LP first presenting as a TTP-like syndrome has never been reported. Here, we describe the case of a previously healthy 45-year-old woman who developed simultaneously these two conditions and then we briefly review the literature on the topic, emphasizing the previous cases of concurrent initial diagnosis of both SLE and MCD (n = 7) and SLE and TTP (n = 72). In conclusion, renal biopsy is central to the management of SLE patients with nephrotic syndrome. Furthermore, in a SLE patient with anemia and thrombocytopenia, TTP should be part of the differential diagnosis, even when no schistocytes were detected in peripheral blood smear.

Entities:  

Keywords:  Minimal change disease; NSAIDs; Podocytopathy; Systemic lupus erythematosus; Thrombotic microangiopathy; Thrombotic thrombopenic purpura

Mesh:

Substances:

Year:  2015        PMID: 26384822     DOI: 10.1007/s10067-015-3069-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  39 in total

1.  ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes.

Authors:  G Zini; G d'Onofrio; C Briggs; W Erber; J M Jou; S H Lee; S McFadden; J L Vives-Corrons; N Yutaka; J F Lesesve
Journal:  Int J Lab Hematol       Date:  2011-11-15       Impact factor: 2.877

2.  Frequency of microangiopathic hemolytic anemia in patients with systemic lupus erythematosus exacerbation: Distinction from thrombotic thrombocytopenic purpura, prognosis, and outcome.

Authors:  Sylvia Dold; Ranju Singh; Haroon Sarwar; Yamini Menon; Liliana Candia; Luis R Espinoza
Journal:  Arthritis Rheum       Date:  2005-12-15

3.  Minimal-change nephropathy associated with systemic lupus erythematosus.

Authors:  B Guery; F Martinez; H Beaufils; G Deray
Journal:  Nephrol Dial Transplant       Date:  1997-09       Impact factor: 5.992

4.  A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: just a coincidence?

Authors:  Y T Wang; H H Chou; F F Chen; M J Chen; Y Y Chiou
Journal:  Lupus       Date:  2006       Impact factor: 2.911

Review 5.  Microangiopathic haemolytic anaemia resembling thrombotic thrombocytopenic purpura in systemic lupus erythematosus: the role of ADAMTS13.

Authors:  Frederick Lansigan; Iris Isufi; Clement E Tagoe
Journal:  Rheumatology (Oxford)       Date:  2010-12-11       Impact factor: 7.580

6.  Microangiopathic haemolytic anaemia secondary to lupus nephritis: an important differential diagnosis of thrombotic thrombocytopenic purpura.

Authors:  B J Hunt; S Tueger; J Pattison; J Cavenagh; D P D'Cruz
Journal:  Lupus       Date:  2007       Impact factor: 2.911

7.  Naproxen-induced recurrent aseptic meningitis.

Authors:  B B Weksler; A M Lehany
Journal:  DICP       Date:  1991-11

8.  Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.

Authors:  Tomomi Matsuyama; Masataka Kuwana; Masanori Matsumoto; Ayami Isonishi; Shigeko Inokuma; Yoshihiro Fujimura
Journal:  Thromb Haemost       Date:  2009-08       Impact factor: 5.249

9.  Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency.

Authors:  James N George; Qiaofang Chen; Cassie C Deford; Zayd Al-Nouri
Journal:  J Clin Apher       Date:  2012-08-28       Impact factor: 2.821

10.  Nonsteroidal Anti-inflammatory Drug Induced Thrombotic Thrombocytopenic Purpura.

Authors:  Karlos Z Oregel; Jeremy Ramdial; Stefan Glück
Journal:  Clin Med Insights Blood Disord       Date:  2013-11-14
View more
  1 in total

1.  Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report.

Authors:  Lin Liu; Brian Murray; John E Tomaszewski
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.